Literature DB >> 8430046

Controlled delivery of pilocarpine. 1. In vitro characterization of Gelfoam matrices.

S R Nadkarni1, S H Yalkowsky.   

Abstract

The potential of Gelfoam absorbable gelatin sponge as a carrier for ophthalmic delivery of pilocarpine was examined. Prolonged in vitro release of pilocarpine was achieved through pharmaceutical modification of the device by embedding a retardant in the pores. The device embedded with cetyl ester wax released pilocarpine in a zero-order pattern (release exponent = 0.93 +/- 0.04) for up to 5 hr. This result corresponded well with a linear penetrant uptake by this device. The device impregnated with polyethylene glycol 400 monostearate exhibited anomalous drug transport with a release exponent of 0.63 +/- 0.02. The absorption of water by this retardant and the formation of a gel layer on the surface slowed the penetration of the release medium into the deeper sections of the matrix, as well as the rapid outward diffusion of drug, resulting in a prolonged release of pilocarpine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430046     DOI: 10.1023/a:1018985332376

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-12       Impact factor: 3.534

2.  Visual effects of pilocarpine in glaucoma comparative study of administration by eyedrops or by ocular therapeutic systems.

Authors:  H S Brown; G Meltzer; R C Merrill; M Fisher; C Ferré; V A Place
Journal:  Arch Ophthalmol       Date:  1976-10

3.  Ocular evaluation of methylcellulose vehicle in albino rabbits.

Authors:  S S Chrai; J R Robinson
Journal:  J Pharm Sci       Date:  1974-08       Impact factor: 3.534

4.  Drug release from wax matrices. I. Analysis of data with first-order kinetics and with the diffusion-controlled model.

Authors:  J B Schwartz; A P Simonelli; W I Higuchi
Journal:  J Pharm Sci       Date:  1968-02       Impact factor: 3.534

5.  Quantitative evaluation of topically applied pilocarpine in the precorneal area.

Authors:  A G Thombre; K J Himmelstein
Journal:  J Pharm Sci       Date:  1984-02       Impact factor: 3.534

6.  Ophthalmic drug delivery systems.

Authors:  J W Shell
Journal:  Surv Ophthalmol       Date:  1984 Sep-Oct       Impact factor: 6.048

Review 7.  Pharmacokinetics of topically applied ophthalmic drugs.

Authors:  J W Shell
Journal:  Surv Ophthalmol       Date:  1982 Jan-Feb       Impact factor: 6.048

8.  Analysis of commercial pilocarpine preparations by high-performance liquid chromatography.

Authors:  M V Drake; J J O'Donnell; R P Sandman
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

9.  Cross-linking of gelatine by dehydration.

Authors:  I V Yannas; A V Tobolsky
Journal:  Nature       Date:  1967-07-29       Impact factor: 49.962

10.  Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.

Authors:  V H Lee; J R Robinson
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

  10 in total
  2 in total

1.  Intrapericardial delivery of gelfoam enables the targeted delivery of Periostin peptide after myocardial infarction by inducing fibrin clot formation.

Authors:  Brian D Polizzotti; Shima Arab; Bernhard Kühn
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

2.  Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.

Authors:  Mona G Arafa; Germeen N S Girgis; Marwa S El-Dahan
Journal:  Int J Nanomedicine       Date:  2020-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.